Protalix BioTherapeutics, Inc. (DE) financial statements, including revenue, expenses, profit, and loss
The total revenue of PLX for the last quarter is 13.47 M USD, and it's 259.50% higher compared to the previous quarter. The net income of Q2 24 is -2.20 M USD.